Poliovax Purple Book BLA 103940

BLA number
103940
Proprietary names
Poliovax
Proper names
Poliovirus Vaccine Inactivated (Human Diploid Cell)
Applicant
Sanofi Vaccines Canada Ltd.
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001PoliovaxPoliovirus Vaccine Inactivated (Human Diploid Cell)351(a)0.5MLInjectionSubcutaneousVialDiscLicensed2000-02-24
002PoliovaxPoliovirus Vaccine Inactivated (Human Diploid Cell)351(a)0.5MLInjectionIntramuscularVialDiscLicensed2000-02-24

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-05-01U001Poliovax351(a)DiscSanofi Vaccines Canada Ltd.
2026-05-01U002Poliovax351(a)DiscSanofi Vaccines Canada Ltd.
2022-01-01U001Poliovax351(a)DiscSanofi Pasteur Limited
2022-01-01U002Poliovax351(a)DiscSanofi Pasteur Limited
2021-05-01U001Poliovax351(a)DiscSanofi Pasteur Limited
2020-08-01R001Poliovax351(a)DiscSanofi Pasteur Limited

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2022-01-01002Poliovax351(a)DiscLicensed2000-02-24
2020-08-01001Poliovax351(a)DiscLicensed2000-02-24